More than four billion dollars in capital commitments landed in Indiana in a single day — semiconductors in Tippecanoe County, battery storage in St. Joseph County, radiopharmaceuticals in Boone County — and the press coverage of every one of those announcements buried the structural risk sitting underneath it. This brief names what was missed and what Indiana C&I operators and suppliers need to act on now.

SK Hynix Breaks Ground in West Lafayette — and the Detail the Ceremony Buried

SK Hynix held its ceremonial groundbreaking at Purdue University's Holloway Gymnasium for its HBM packaging and R&D facility in Purdue Research Park. The confirmed investment is more than four billion dollars, up from the $3.87 billion figure in the original Commerce Department documentation. Up to $458 million in CHIPS Act direct funding backs the project. The cleanroom targets October 2028, with mass production of HBM4E and HBM5-class products beginning in the second half of 2029. Roughly 1,000 direct jobs at full operation, with approximately 7,000 total direct and indirect jobs projected across more than 100 planned ecosystem partners.

Here is the detail the ceremony coverage didn't name: SK Hynix confirmed at the Hot Chips conference four days before breaking ground that hybrid bonding will not be ready for HBM4E — it's pushed to HBM5, around 2029 to 2030. That means the Indiana cleanroom opens on MR-MUF bonding equipment. Whether that changes depends on where SK Hynix routes its next-generation hybrid bonding lines. They already have a 19 trillion won advanced packaging plant going up in Cheongju for 2027. If SK Hynix routes HBM5 hybrid bonding capacity to Indiana rather than Cheongju, a second capital event becomes plausible in the early 2030s. That is not a certainty — but it is a scenario Indiana suppliers should be positioned for.

More immediately relevant: the procurement wave concentrated in the 2027-to-2030 window is the opportunity in front of you now. If your operation produces ultra-pure chemicals, specialty gases, precision metrology equipment, or substrate materials, vendor qualification for a cleanroom of this scale typically opens 18 to 24 months ahead of commissioning — which puts the qualification window opening in 2026 and closing fast. Purdue Research Foundation is the site-development entry point. SK Hynix's U.S. procurement organization runs the actual vendor qualification process. Those are two separate conversations, and both need to start soon.

Samsung SDI Takes Full Control of New Carlisle — and Indiana Now Holds North America's ESS Concentration

Samsung SDI is taking full ownership of the $3.5 billion, 27-gigawatt-hour battery cell plant in New Carlisle — its first wholly owned battery facility in North America — and pivoting the plant to include an energy storage system line targeting U.S. grid storage demand.

New Carlisle becomes Samsung SDI's second active Indiana ESS production node alongside StarPlus Energy in Kokomo. To be precise about what that means: StarPlus is a Stellantis-Samsung SDI joint venture with mixed EV and ESS cell production, operating under a one-billion-dollar four-year supply contract. New Carlisle is different — wholly owned by Samsung SDI and configured specifically for grid-scale ESS from the start. Taken together, Samsung SDI's North American ESS capacity is now geographically concentrated in Indiana, which materially alters the calculus for in-state suppliers and logistics providers.

The ESS pivot at New Carlisle is also structurally clean: the shell reportedly has no EV machinery installed, so Samsung SDI avoids the sunk-cost retrofit problem competitors face converting completed EV lines. If your operation serves materials, logistics, or maintenance for battery manufacturing, the question you need to answer is whether you've mapped the supply chain differences between EV cell production and grid-scale ESS production. Those are not identical requirements.

RayzeBio's $173M Whitestown Facility — and the Isotope Supply Risk No One Is Naming

RayzeBio, a Bristol Myers Squibb company, is investing more than $173 million to build an approximately 450,000-square-foot radiopharmaceutical manufacturing facility at Anson Industrial Park in Boone County — nearly six times the size of its existing 77,000-square-foot Indianapolis operation. Up to 100 new jobs at average annual wages above $130,000, projected by end of 2029.

The announcement no one is interrogating: there is no disclosed isotope supply agreement. The Whitestown facility will manufacture actinium-225-based therapies, and legacy DOE Ac-225 supply from Oak Ridge has run at roughly one to two curies per year. Accelerator- and reactor-based capacity at sites like Niowave, TRIUMF, and DOE Isotope Program facilities is scaling — but still far short of projected clinical demand. Bayer, Eli Lilly, and Novartis have already locked long-term Ac-225 deals with Niowave, ITM, and Eckert & Ziegler respectively. RayzeBio's $173 million Whitestown commitment is partially a bet on securing upstream isotope supply that is currently uncontracted.

TerraPower Isotopes announced a $450 million Ac-225 production facility in March 2026 — targeting a 20-fold capacity increase — but it won't be operational until roughly 2029, exactly when the Whitestown plant is projected to run. That queue will close before the plant opens. Watch for a BMS supply agreement with TerraPower, Niowave, or a DOE national lab — that contract is the real gating factor on whether this facility reaches commercial production on schedule.

Questions for Your Morning Huddle

Q: What should Indiana suppliers do right now to get into the SK Hynix vendor ecosystem?

A: Start two separate conversations immediately: Purdue Research Foundation handles site-development entry, while SK Hynix's U.S. procurement organization runs the actual vendor qualification process. Vendor qualification for a cleanroom of this scale typically opens 18 to 24 months ahead of commissioning, which means the window for the October 2028 cleanroom is open now and narrowing fast.

Q: How does Samsung SDI's full ownership of New Carlisle change the supply chain opportunity for Indiana manufacturers?

A: Samsung SDI now operates two Indiana ESS production nodes — New Carlisle and StarPlus Energy in Kokomo — making Indiana the geographic concentration point for Samsung SDI's North American grid-scale battery capacity. Suppliers that serve battery manufacturing should audit their product and service fit against grid-scale ESS requirements, which differ from EV cell production in materials, logistics, and maintenance needs.

Q: What is the biggest unresolved risk in the RayzeBio Whitestown announcement?

A: RayzeBio has not disclosed an isotope supply agreement for actinium-225, and major Ac-225 suppliers have already committed long-term capacity to Bayer, Eli Lilly, and Novartis. The facility is betting on upstream supply that is not yet contracted, and the most meaningful signal to watch for is a BMS supply deal with TerraPower Isotopes, Niowave, or a DOE national lab.

Q: Is the SK Hynix bonding technology change a risk to the Indiana facility?

A: Not to the initial build — the Indiana cleanroom opens on MR-MUF bonding equipment, which is the current production technology. The open question is whether SK Hynix routes its next-generation hybrid bonding lines to Indiana or to its Cheongju facility for 2027. If Indiana gets HBM5 hybrid bonding capacity, a second capital event in the early 2030s becomes plausible. That is a scenario to position for, not a certainty to count on.

For context on how Indiana utility rates and grid costs affect the economics behind large capital deployments like these, see NIPSCO's 12-Day Gary Blackout, the IURC Contradiction Behind It, and What Indiana Manufacturers Must Model Before September 8 and AES Indiana Rate Deadline September 5: What Indiana Manufacturers Need to Model Before the IURC Vote.